Sourav Sinha

2023 Millennium fellow. Venture Capitalist. Healthcare & Biotech Executive Sourav is a biotechnology and longevity investor and entrepreneur. He is a co-founder and Chairman of Jumpstart Fertility—developing IVF innovations to enable more successful IVF cycles. Jumpstart is working with the leading IVF clinics in the US and around the world, to bring these breakthrough technologies to families all over the world. Sourav is also Partner at Bedford Bridge Capital, a growth-stage venture fund supporting biotechnology companies at the intersection of healthcare, AI/technology, and longevity. Sourav was previously the Founding General Partner at Longevity Vision Fund, which became one of the largest funds in the longevity sector. Sourav has also been a co-founder and/or founding executive across multiple companies across immune-oncology and longevity, including Celularity (NASDAQ: CELU), the first spinout of Celgene. Sourav was selected as a 2023 Millennium Fellow of the Atlantic Council—a transatlantic, think tank focused on international affairs and geopolitics. Sourav has been an invited participant/speaker at World Economic Forum Annual Meeting in Davos, Future Investment Initiative, UNGA, and Horasis Extraordinary Meeting on the United States & Asia. Sourav holds an A.B. in Molecular Biology and Biochemistry from Dartmouth College and is a graduate of Singularity University’s Global Solutions Program. Sourav’s research has been published in top-tier journals and industry textbooks and was featured on the Forbes 30 Under 30 list for Healthcare in 2018.